Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...

Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Google Drive is a storage solution, but most of us treat it like a digital junk drawer. Files end up in random folders, ...

Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Accounting automation allows accounting firms to offer real-time insights to clients by reducing the time spent on manual processes. It creates space for ...

Shenzhen, Zhenjiang, Xiamen and Nanchang – approached developing low-carbon policies over the course of almost a decade ...

Real-time security clearances are becoming increasingly common in manufacturing of advanced-node semiconductors, where data ...

Nigerian entrepreneurs do not build businesses to stay small, but their growth requires systems that defy even the ...

(Dec 10): Coupang CEO Park Dae-jun resigned over his failure to prevent South Korea’s largest-ever data breach, which set off ...